ROC1 promotes the malignant progression of bladder cancer by regulating p-IkappaBalpha/NF-kappaB signaling.
Wu Q, Zhou X, Li P, Ding M, You S, Xu Z, Ye J, Chen X, Tan M, Wang J, Wang W, Qiu J.
J Exp Clin Cancer Res. 2021 May 7;40(1):158. doi: 10.1186/s13046-021-01935-5.
UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes lymphatic metastasis in bladder cancer.
Li W, Chen C, Zheng H, Lin Y, An M, Liu D, Zhang Y, Gao M, Lan T, He W.
J Clin Invest. 2024 Jul 1;134(13):e179122. doi: 10.1172/JCI179122.
LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment.
Chen C, He W, Huang J, Wang B, Li H, Cai Q, Su F, Bi J, Liu H, Zhang B, Jiang N, Zhong G, Zhao Y, Dong W, Lin T.
Nat Commun. 2018 Sep 20;9(1):3826. doi: 10.1038/s41467-018-06152-x.
Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall.
Feldman A, Borak S, Rais-Bahrami S, Gordetsky J.
Int J Surg Pathol. 2018 Apr;26(2):120-125. doi: 10.1177/1066896917741550. Epub 2017 Nov 23.
Malignant mesenchymoma of the bladder.
Terada Y, Saito I, Morohoshi T, Niijima T.
Cancer. 1987 Aug 15;60(4):858-63. doi: 10.1002/1097-0142(19870815)60:4<858::aid-cncr2820600423>3.0.co;2-l.
A model of malignant urinary bladder tumor in rabbits.
Nemoto R, Mori H, Iwata K, Kato T, Harada M.
Tohoku J Exp Med. 1981 Jul;134(3):257-63. doi: 10.1620/tjem.134.257.
Bladder cancer.
[No authors listed]
Br Med J (Clin Res Ed). 1981 Mar 28;282(6269):1012-3.
SECONDARY MALIGNANT DISEASE OF BONE.
CLAIN A.
Br J Cancer. 1965 Mar;19(1):15-29. doi: 10.1038/bjc.1965.3.
CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
Zhang XG, Zhang T, Li CY, Zhang MH, Chen FM.
Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.
[Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow].
Nawroth R, Weckermann D, Retz M.
Urologe A. 2014 Apr;53(4):514-8. doi: 10.1007/s00120-014-3445-0.
